These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35129895)

  • 1. [Terbinafine resistance explains treatment failure in a patient with tinea corporis].
    Buil JB; Bronckers IMGJ; Driessen RJB; Do Nguyen Dan T; Melchers WJG; Verweij PE
    Ned Tijdschr Geneeskd; 2021 Nov; 165():. PubMed ID: 35129895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on the myriad antifungal resistance mechanisms in dermatophytes and the place of experimental and existential therapeutic agents for
    Sardana K; Sharath S; Khurana A; Ghosh S
    Expert Rev Anti Infect Ther; 2023; 21(9):977-991. PubMed ID: 37606343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case of tinea corporis due to terbinafine-resistant Trichophyton interdigitale.
    Kakurai M; Harada K; Maeda T; Hiruma J; Kano R; Demitsu T
    J Dermatol; 2020 Apr; 47(4):e104-e105. PubMed ID: 31994232
    [No Abstract]   [Full Text] [Related]  

  • 4. A new mutation in the SQLE gene of Trichophyton mentagrophytes associated to terbinafine resistance in a couple with disseminated tinea corporis.
    Hsieh A; Quenan S; Riat A; Toutous-Trellu L; Fontao L
    J Mycol Med; 2019 Dec; 29(4):352-355. PubMed ID: 31611164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistant tinea corporis/cruris: Response to voriconazole.
    Khurana A; Agarwal A; Agrawal D; Sardana K; Singh A; Chowdhary A
    J Mycol Med; 2022 Nov; 32(4):101306. PubMed ID: 35785725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End of the road for terbinafine? Results of a pragmatic prospective cohort study of 500 patients.
    Singh S; Shukla P
    Indian J Dermatol Venereol Leprol; 2018; 84(5):554-557. PubMed ID: 29893296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of
    Khurana A; Masih A; Chowdhary A; Sardana K; Borker S; Gupta A; Gautam RK; Sharma PK; Jain D
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients.
    Millikan LE
    Cutis; 2001 Jul; 68(1 Suppl):6-14. PubMed ID: 11499333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene.
    Singh A; Masih A; Khurana A; Singh PK; Gupta M; Hagen F; Meis JF; Chowdhary A
    Mycoses; 2018 Jul; 61(7):477-484. PubMed ID: 29577447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terbinafine resistance in dermatophytes: Time to revisit alternate antifungal therapy.
    Gaurav V; Bhattacharya SN; Sharma N; Datt S; Kumar P; Rai G; Singh PK; Taneja B; Das S
    J Mycol Med; 2021 Mar; 31(1):101087. PubMed ID: 33360137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oral terbinafine versus itraconazole in treatment of dermatophytic infection of skin - A prospective, randomized comparative study.
    Bhatia A; Kanish B; Badyal DK; Kate P; Choudhary S
    Indian J Pharmacol; 2019; 51(2):116-119. PubMed ID: 31142947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open clinical study of the efficacy and safety of terbinafine cream 1% in children with tinea corporis and tinea cruris.
    Bakos L; Brito AC; Castro LC; Gontijo B; Lowy G; Reis CM; Ribeiro AM; Souza FH; Villar Mdo L; Zaitz C
    Pediatr Infect Dis J; 1997 Jun; 16(6):545-8. PubMed ID: 9194102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates.
    Salehi Z; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1841-1846. PubMed ID: 29980898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tinea corporis presenting as disseminated verrucous plaques caused by Arthroderma incurvatum in a young Indian boy.
    Gupta V; Sahoo AK; Singh G; Agarwal R; Xess I; Agarwal S; Gupta S
    Australas J Dermatol; 2017 Nov; 58(4):e265-e267. PubMed ID: 28731578
    [No Abstract]   [Full Text] [Related]  

  • 15. [Extensive tinea corporis due to a terbinafine-resistant Trichophyton mentagrophytes isolate of the Indian genotype in a young infant from Bahrain in Germany].
    Süß A; Uhrlaß S; Ludes A; Verma SB; Monod M; Krüger C; Nenoff P
    Hautarzt; 2019 Nov; 70(11):888-896. PubMed ID: 31098692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tinea unguium caused by terbinafine-resistant Trichophyton rubrum successfully treated with fosravuconazole.
    Noguchi H; Matsumoto T; Hiruma M; Kimura U; Kano R; Yaguchi T; Fukushima S; Ihn H
    J Dermatol; 2019 Dec; 46(12):e446-e447. PubMed ID: 31353607
    [No Abstract]   [Full Text] [Related]  

  • 17. Terbinafine. An update of its use in superficial mycoses.
    McClellan KJ; Wiseman LR; Markham A
    Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Antifungal Agents and New Formulations Against Dermatophytes.
    Gupta AK; Foley KA; Versteeg SG
    Mycopathologia; 2017 Feb; 182(1-2):127-141. PubMed ID: 27502503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiological prevalence and antifungal sensitivity patterns of dermatophytosis in India - A multicentric study.
    Tahiliani S; Saraswat A; Lahiri AK; Shah A; Hawelia D; Shah GK; Girdhar M; Rao PN; Raghav PA; Agarwal P; Kharkar RD; Gupta RP; Udare S; Hegde S; Haldar S
    Indian J Dermatol Venereol Leprol; 2021; 87(6):800-806. PubMed ID: 34160163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.